Carlo Tascini

35PUBLICATIONS
248CO-AUTHORS
Medical bacteriologyMedical infection agents (incl. prions)Nanotoxicology, health and safetyPharmacogenomicsMedical microbiology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Oct 29, 2026
Real-World Use of Rezafungin for the Treatment of Challenging Aspergillus Infections.

|Sep 26, 2026
Clinical, Microbiological and Genomic Characterization of OXA-48-Producing Klebsiella pneumoniae ST395 Circulating in a Secondary-Care Hospital in North-Eastern Italy, 2024-2025.

|Jul 25, 2026
Oritavancin as consolidation or suppressive therapy in infective endocarditis and device-related infections: real-world experience with therapeutic drug monitoring.

|May 28, 2026
Case Commentary: When susceptibility is not enough in recurrent Burkholderia cenocepacia infection.

|Mar 13, 2026
Current opinion on the potential role of liposomal amphotericin B in underexplored clinical scenarios.

Jacopo Angelini, Sara Ferin, Luca Martini

|Feb 27, 2026
Target Fidelity and Failure: Structure-Activity Relationship of High-Molecular-Mass Penicillin-Binding Proteins (HMM-PBPs) in Refractory Granulicatella adiacens Endocarditis.

Paola Conti, Alberto Pagotto, Sebastiano A Fortuna

Pageof 6

Frequent Collaborators

7 joint publications

Simone Giuliano

5 joint publications

Jacopo Angelini

4 joint publications

Livio Pagano

4 joint publications

Jon Salmanton-García